天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 1612-76-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1612-76-6
Chemical Structure| 1612-76-6
Structure of 1612-76-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1612-76-6 ]

Related Doc. of [ 1612-76-6 ]

Alternatived Products of [ 1612-76-6 ]
Product Citations

Product Details of [ 1612-76-6 ]

CAS No. :1612-76-6 MDL No. :MFCD00126383
Formula : C8H7N3O Boiling Point : -
Linear Structure Formula :- InChI Key :CQSFYCBGVMWPCM-UHFFFAOYSA-N
M.W : 161.16 Pubchem ID :15363
Synonyms :

Calculated chemistry of [ 1612-76-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.14
TPSA : 64.94 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.53
Log Po/w (XLOGP3) : 1.63
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 1.17
Log Po/w (SILICOS-IT) : 1.22
Consensus Log Po/w : 1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.48
Solubility : 0.536 mg/ml ; 0.00332 mol/l
Class : Soluble
Log S (Ali) : -2.61
Solubility : 0.399 mg/ml ; 0.00248 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.01
Solubility : 0.156 mg/ml ; 0.000971 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.28

Safety of [ 1612-76-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1612-76-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1612-76-6 ]

[ 1612-76-6 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 127116-19-2 ]
  • [ 1612-76-6 ]
  • 2-{4-[2-methyl-6-(5-phenyl-[1,3,4]oxadiazol-2-ylamino)pyrimidin-4-yl]piperazin-1-yl}ethanol [ No CAS ]
YieldReaction ConditionsOperation in experiment
23% With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate; In N,N-dimethyl-formamide; at 110℃; for 36h;Schlenk technique; Inert atmosphere; General procedure: A 10-ml Schlenk tube equipped with a stir-bar was charged with compound 1 (0.2 mmol), compound 2 (0.3 mmol), Pd(OAc)2 (0.02 mmol), Xantphos (0.04 mmol), NaOtBu (0.3 mmol), anhydrous DMF (2 mL).The reaction tube was purged with argon. The Schlenk tube was placed in an oil-bath at 110 oC for 36 hours and then cooled to room temperature. The reaction mixture was extracted with EtOAc (3 × 20 mL). The combined organic phase was dried over MgSO4 and concentrated under reduced pressure and the crude residue purified by flash chromatography on silica gel. The purified material was dried in vacuo to afford the corresponding products 3a-w.
23% With xantphos; palladium diacetate; sodium t-butanolate; In N,N-dimethyl-formamide; at 110℃; for 36h;Schlenk technique; Inert atmosphere; In a 10 ml Schlenk tube, add compound 1c (51.2 mg, 0.2 mmol), 5-phenyl- [1,3,4]oxadiazole-2-amino (48.3 mg, 0.3 mmol), Pd (OAc) 2 (4.5 mg, 0.02 mmol), xantphos (23mg, 0.04mmol), NaOtBu (29mg, 0.3mmol) and anhydrous DMF (2mL) under the protection of argon,The reaction tube was placed in an oil bath at 110 C. for 36 h for a Buchwald-Hartwig reaction, then cooled to room temperature, and the reaction mixture was extracted with EtOAc (3 × 20 mL). The organic phase was dried over MgSO4 and concentrated under reduced pressure. The corresponding product 2a (17.5 mg) was separated on a silica gel column, white solid, melting point: 180 C, yield 23%, purity 96%.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 1612-76-6 ]

Aryls

Chemical Structure| 51039-53-3

[ 51039-53-3 ]

2-Bromo-5-phenyl-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 829-35-6

[ 829-35-6 ]

2-(4-methoxyphenyl)-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 1483-31-4

[ 1483-31-4 ]

2-Chloro-5-phenyl-1,3,4-oxadiazole

Similarity: 0.71

Chemical Structure| 91063-19-3

[ 91063-19-3 ]

3-(Benzyloxy)-6-chloropyridazine

Similarity: 0.61

Chemical Structure| 3004-42-0

[ 3004-42-0 ]

5-Phenyl-1,3,4-oxadiazole-2(3H)-thione

Similarity: 0.60

Amines

Chemical Structure| 69741-92-0

[ 69741-92-0 ]

5-(tert-Butyl)-1,3,4-oxadiazol-2-amine

Similarity: 0.69

Chemical Structure| 52838-39-8

[ 52838-39-8 ]

5-Methyl-1,3,4-oxadiazol-2-amine

Similarity: 0.59

Chemical Structure| 39614-78-3

[ 39614-78-3 ]

6-Ethoxypyridazin-3-amine

Similarity: 0.55

Chemical Structure| 57699-88-4

[ 57699-88-4 ]

1-Benzyl 2-(tert-butyl) hydrazine-1,2-dicarboxylate

Similarity: 0.51

Chemical Structure| 121041-41-6

[ 121041-41-6 ]

6-(4-Methoxyphenoxy)pyridazin-3-amine

Similarity: 0.51

Related Parent Nucleus of
[ 1612-76-6 ]

Oxadiazoles

Chemical Structure| 51039-53-3

[ 51039-53-3 ]

2-Bromo-5-phenyl-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 829-35-6

[ 829-35-6 ]

2-(4-methoxyphenyl)-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 1483-31-4

[ 1483-31-4 ]

2-Chloro-5-phenyl-1,3,4-oxadiazole

Similarity: 0.71

Chemical Structure| 69741-92-0

[ 69741-92-0 ]

5-(tert-Butyl)-1,3,4-oxadiazol-2-amine

Similarity: 0.69

Chemical Structure| 3004-42-0

[ 3004-42-0 ]

5-Phenyl-1,3,4-oxadiazole-2(3H)-thione

Similarity: 0.60

; ;